Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia — Stella

Home/Type 2 Diabetes (T2DM)/A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabetes (T2DM) trials

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(4 sites)

Indonesia

RS Universitas Indonesia, Depok, West Java

RSUP Fatmawati, Jakarta

RSUP Persahabatan, Jakarta

RSUPN Dr. Cipto Mangunkusumo, Jakarta

Key details

Phase

Large-scale testing

Sponsor

BrightGene Bio-Medical Technology Co., Ltd.

Enrollment target

~477 participants

Started

July 2025

Primary completion

July 2026

Age range

18 Years – 75 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.